Cargando…

Blood Immune Cells as Biomarkers in Long-Term Surviving Patients with Advanced Non-Small-Cell Lung Cancer Undergoing a Combined Immune/Chemotherapy

SIMPLE SUMMARY: Tumor cells can evade recognition and killing via immune cells by expressing co-inhibitory membrane molecules, which suppress the activity of tumor-specific T cells. Immune checkpoint inhibitor (ICI) therapies act by blocking these inhibitory pathways via monoclonal antibodies. Due t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Möller, Miriam, Schütte, Wolfgang, Turzer, Steffi, Seliger, Barbara, Riemann, Dagmar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572005/ https://www.ncbi.nlm.nih.gov/pubmed/37835567 http://dx.doi.org/10.3390/cancers15194873

Ejemplares similares

Monitoring Blood Immune Cells in Patients with Advanced Small Cell Lung Cancer Undergoing a Combined Immune Checkpoint Inhibitor/Chemotherapy
por: Riemann, Dagmar, et al.
Publicado: (2023)

Blood Immune Cell Biomarkers in Patient With Lung Cancer Undergoing Treatment With Checkpoint Blockade
por: Möller, Miriam, et al.
Publicado: (2020)

Blood Immune Cell Biomarkers in Lung Cancer Patients Undergoing Treatment with a Combination of Chemotherapy and Immune Checkpoint Blockade
por: Möller, Miriam, et al.
Publicado: (2022)

High PD-L1/CD274 Expression of Monocytes and Blood Dendritic Cells Is a Risk Factor in Lung Cancer Patients Undergoing Treatment with PD1 Inhibitor Therapy
por: Riemann, Dagmar, et al.
Publicado: (2020)

Granulocyte-to-dendritic cell-ratio as marker for the immune monitoring in patients with renal cell carcinoma
por: Riemann, Dagmar, et al.
Publicado: (2014)

Immune Therapy Resistance and Immune Escape of Tumors
por: Seliger, Barbara, et al.
Publicado: (2021)

Identification of patient-specific and tumor-shared T cell receptor sequences in renal cell carcinoma patients
por: Massa, Chiara, et al.
Publicado: (2017)

Evaluation of TCR amplification in tumor lesions and peripheral blood of renal cell carcinoma patients
por: Massa, Chiara, et al.
Publicado: (2013)

Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes
por: Tsavaris, N, et al.
Publicado: (2002)

Survival and biomarkers for cachexia in non‐small cell lung cancer receiving immune checkpoint inhibitors
por: Murata, Daiki, et al.
Publicado: (2023)

The Dark Side of Dendritic Cells: Development and Exploitation of Tolerogenic Activity That Favor Tumor Outgrowth and Immune Escape
por: Seliger, Barbara, et al.
Publicado: (2013)

Combinatorial Approaches With Checkpoint Inhibitors to Enhance Anti-tumor Immunity
por: Seliger, Barbara
Publicado: (2019)

First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers
por: Fan, Ying, et al.
Publicado: (2019)

Stereotactic Body Radiation Therapy Is Effective and Safe in Patients with Early-Stage Non-Small Cell Lung Cancer with Low Performance Status and Severe Comorbidity
por: Turzer, Martin, et al.
Publicado: (2011)

Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer
por: Stares, M., et al.
Publicado: (2022)

Correlation between Circulating miR-16, miR-29a, miR-144 and miR-150, and the Radiotherapy Response and Survival of Non-Small-Cell Lung Cancer Patients
por: Bache, Matthias, et al.
Publicado: (2023)

Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma
por: Eckert, Alexander W., et al.
Publicado: (2016)

Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in Denmark
por: Dalvi, Tapashi, et al.
Publicado: (2023)

The Fungal Quorum-Sensing Molecule Farnesol Activates Innate Immune Cells but Suppresses Cellular Adaptive Immunity
por: Leonhardt, Ines, et al.
Publicado: (2015)

VHL-dependent alterations in the secretome of renal cell carcinoma: Association with immune cell response?
por: Stehle, Franziska, et al.
Publicado: (2015)

Effect of Sintilimab combined with Chemotherapy on Tumor Markers and Immune Function of advanced non-small cell lung cancer
por: Liang, Xiaoyan, et al.
Publicado: (2021)

Immune Escape Mechanisms and Their Clinical Relevance in Head and Neck Squamous Cell Carcinoma
por: Seliger, Barbara, et al.
Publicado: (2020)

Standard radiotherapy but not chemotherapy impairs systemic immunity in non-small cell lung cancer
por: Talebian Yazdi, Mehrdad, et al.
Publicado: (2016)

Immune Cell and Biochemical Biomarkers in Advanced Laryngeal Cancer
por: Jotic, Ana, et al.
Publicado: (2022)

Correction to: Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma
por: Eckert, Alexander W., et al.
Publicado: (2018)

Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non‐small cell lung cancer
por: Kuo, Chih‐Hsi Scott, et al.
Publicado: (2019)

Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: Perioperative and Survival Outcomes
por: Ma, Xiao, et al.
Publicado: (2022)

Comments on ‘Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer’
por: Takada, K., et al.
Publicado: (2022)

A new immune signature for survival prediction and immune checkpoint molecules in non-small cell lung cancer
por: Han, Shuai, et al.
Publicado: (2023)

Survival of patients with small cell lung cancer undergoing lung resection in England, 1998–2009
por: Lüchtenborg, Margreet, et al.
Publicado: (2014)

Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies
por: Bauer, Marcus, et al.
Publicado: (2021)

Awaken Immune Cells by Hapten Enhanced Intratumoral Chemotherapy with Penicillin Prolong Pancreatic Cancer Survival
por: Yu, Baofa, et al.
Publicado: (2023)

Molecular mechanisms of human herpes viruses inferring with host immune surveillance
por: Jasinski-Bergner, Simon, et al.
Publicado: (2020)

Prognostic biomarkers correlated with immune infiltration in non‐small cell lung cancer
por: Xu, Fei, et al.
Publicado: (2022)

Intracranial activity of first-line immune checkpoint inhibitors combined with chemotherapy in advanced non-small cell lung cancer
por: Huang, Zhe, et al.
Publicado: (2023)

Synergistic effects of IL-4 and TNFα on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation
por: Quandt, Dagmar, et al.
Publicado: (2014)

Efficacy and Safety of Amrubicin in Small Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors and Chemotherapy
por: Nishimura, Tadashi, et al.
Publicado: (2022)

Pathological Response and Immune Biomarker Assessment in Non-Small-Cell Lung Carcinoma Receiving Neoadjuvant Immune Checkpoint Inhibitors
por: Rojas, Frank, et al.
Publicado: (2022)

Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patients with recurrent small cell lung cancer
por: Althoff, Friederike C., et al.
Publicado: (2023)

Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC
por: Massa, Chiara, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1fn86779crsh9ps0nuq6msmqm6